The DOI matches its Crossref record.
A 5‐hydroxytryptamine receptor in human atrium
Open accessAbstract
The effects of 5‐hydroxytryptamine (5‐HT) were investigated on right atrial appendages obtained from patients treated with β‐adrenoceptor blocking agents who were undergoing open heart surgery. Atrial strips were paced under isometric conditions. 5‐HT increased contractile force to approximately one half of the force produced by a saturating concentration of (−)−isoprenaline. Both 5‐HT and (−)−isoprenaline accelerated the onset of relaxation, as indicated by an abbreviation of time to peak force. The effects of 5‐HT were resistant to blockade by 0.4 μ m (±)‐propranolol, 1μ m (−)−pindolol, 0.4 μ m methiothepin, 4 μ m yohimbine, 0.4 μ m ketanserin, 10 μ m phenoxybenzamine, 1μ m methysergide, 2 μ m MDL 72222 and 20 μ m granisetron. Cocaine 6 μ m potentiated the effects of 5‐HT, increasing the pEC 50 from 6.6 to 7.4. The inotropic potency of 5‐HT is five times greater than that of (−)−noradrenaline. ICS 205930 antagonized competitively the effects of 5‐HT with a pK B of 6.7. In the presence of 0.4 μ m (±)‐propranolol, 10 μ m 5‐HT increased both adenosine 3′:5′ cyclicmonophosphate (cyclic AMP) levels and cyclic AMP‐dependent protein kinase activity by approximately one half and two thirds respectively, of the corresponding effects of 200 μ m (−)−isoprenaline. Both the increase in cyclic AMP levels and the stimulation of protein kinase activity are consistent with the inotropic effects of 5‐HT being mediated by cyclic AMP‐dependent phosphorylation of Ca 2+ channels and of proteins involved in contraction and relaxation. The human atrial 5‐HT receptor resembles the neuronal ‘so called’ 5‐HT 4 receptor of rodents both in increasing cyclic AMP levels and in its affinity for ICS 205930.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular biology of 5-HT receptors
Hannon, J., & Hoyer, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.020 · Cited by 815
Molecular biology of 5-HT receptors
Boess, F. G., & Martin, I. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90059-0 · Cited by 677
5-Hydroxytryptamine receptors in the human cardiovascular system
Kaumann, A. J., & Levy, F. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.004 · Cited by 309
Self-citationReceptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature
Martin, G. R., & Humphrey, P. P. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90058-2 · Cited by 305
Development of a radioligand binding assay for 5‐HT4 receptors in guinea‐pig and rat brain
Grossman, C. J., Kilpatrick, G. J., & Bunce, K. T. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13617.x · Cited by 289
Metadata
- Authors
- Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1990-08
- Volume
- 100
- Issue
- 4
- Pages
- 879-885
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2034438027
- Cited by
- 204
- References
- 0
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 5‐hydroxytryptamine receptor in human atrium. https://app.cochat.ai/papers/10.1111/j.1476-5381.1990.tb14108.x
- The paper
- Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1990). A 5‐hydroxytryptamine receptor in human atrium. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1990.tb14108.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.